Director Exercises and Sells Shares at Travere Therapeutics
Roy D. Baynes, Director at Travere Therapeutics (TVTX), exercised stock options for 4,500 shares on May 5, 2026, selling them immediately in a transaction valued around $210,000. This reduced his direct holdings by approximately 10.71%, from 42,000 to 37,500 shares.
Tickers: $TVTX
Topics: ownership change SEC Form 4 stock options